Clinical outcomes in metastatic renal cell carcinoma (mRCC) treated with combination of nivolumab and cabozantinib (nivo-cabo) in the salvage setting.

被引：1

作者：

Ravindranathan, Deepak

Liu, Yuan

Martini, Dylan J.

Nazha, Bassel

Brown, Jacqueline T.

Russler, Greta

Yantorni, Lauren Beth

Caulfield, Sarah

Master, Viraj A.

Carthon, Bradley Curtis

Kucuk, Omer

Bilen, Mehmet Asim

机构：

[1] Emory Univ, Winship Canc Inst, Atlanta, GA USA

[2] Emory Univ, Dept Biostat & Bioinformat, Atlanta, GA USA

[3] Emory Univ, Dept Hematol & Med Oncol, Sch Med, Atlanta, GA USA

[4] Emory Univ, Dept Hematol & Med Oncol, Atlanta, GA USA

来源：

关键词：

D O I：

10.1200/JCO.2021.39.15_suppl.e16570

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

e16570

引用

页数：3